OrganiGram Holdings (TSE:OGI) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Organigram Holdings Inc. has announced promising preliminary results from a clinical study on its new FAST™ nanoemulsion technology, which offers a faster onset and improved bioavailability of cannabinoids for ingestible products. The technology is set to enhance Organigram’s product line, providing consumers with more control over their dosage experience. Final results of the study, which could significantly impact the adult-use cannabis market, are expected to be published later this year.
For further insights into TSE:OGI stock, check out TipRanks’ Stock Analysis page.